Jim Mazzo, who has been an executive for almost five decades in the ophthalmology industry, is currently on the board of ...

BrightFocus Foundation today announced $15.2 million in new research grants for Alzheimer's disease, macular degeneration, and glaucoma, reinforcing its commitment to advancing scientific discovery ...

ALKU, one of the nation's fastest-growing specialized staffing firms, today announced the opening of a new office in San Diego, California. The office will serve as ALKU's dedicated hub for life ...

The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...

The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...

Regeneron will make its newly approved gene therapy available for free in the U.S. The company hasn't yet decided how much it ...

You might like the sound of this news. In a landmark move, the Food and Drug Administration on Thursday approved the first ...

The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...

A first-of-its-kind gene therapy that can restore hearing in children born deaf has just cleared its final hurdle—and, in a ...

By Sriparna Roy April 23 (Reuters) - The U.S. Food and Drug Administration has approved Regeneron's gene therapy for a rare ...

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss ...

Cystic fibrosis is among the most common, known and studied genetic diseases. It affects over 100,000 people worldwide and ...